glp-1 cons 2026 Employee Benefits Trends: Should You Cover GLP‑1s for Weight Loss? Comparing GLP‑1 Drugs With Other

These include fatty acid oxidation, lipogenesis, glucose uptake, gluconeogenesis, mitochondria biosynthesis, and insulin sensitivity [29,30]

Nocturia disrupting sleep : Waking multiple times nightly to urinate may indicate uncontrolled diabetes, heart failure, sleep apnea, or prostate issues in men

PubMed Central, Brierley, Daniel I., et al

OneSource Specialty Pharma is investing approximately $100 million to expand its drug-device facilities, increasing cartridge filling capacity from 40 million to 200 million units over the next 1824 months

*Based on self-reported member data on a Found program from members with no prior weight loss medication use, who reported weight loss of 12.1% in 6 months on compounded tirzepatide, as of April 2026

Patients who are not obese, or indeed underweight, will still experience weight loss on these medications, so that needs to be balanced with any other potential health benefit.